Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Mar 26;56(4):e01329-17.
doi: 10.1128/JCM.01329-17. Print 2018 Apr.

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis

Affiliations
Multicenter Study

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis

Preeti Pancholi et al. J Clin Microbiol. .

Abstract

We describe results from a multicenter study evaluating the Accelerate Pheno system, a first of its kind diagnostic system that rapidly identifies common bloodstream pathogens from positive blood cultures within 90 min and determines bacterial phenotypic antimicrobial susceptibility testing (AST) results within ∼7 h. A combination of fresh clinical and seeded blood cultures were tested, and results from the Accelerate Pheno system were compared to Vitek 2 results for identification (ID) and broth microdilution or disk diffusion for AST. The Accelerate Pheno system accurately identified 14 common bacterial pathogens and two Candida spp. with sensitivities ranging from 94.6 to 100%. Of fresh positive blood cultures, 89% received a monomicrobial call with a positive predictive value of 97.3%. Six common Gram-positive cocci were evaluated for ID. Five were tested against eight antibiotics, two resistance phenotypes (methicillin-resistant Staphylococcus aureus and Staphylococcus spp. [MRSA/MRS]), and inducible clindamycin resistance (MLSb). From the 4,142 AST results, the overall essential agreement (EA) and categorical agreement (CA) were 97.6% and 97.9%, respectively. Overall very major error (VME), major error (ME), and minor error (mE) rates were 1.0%, 0.7%, and 1.3%, respectively. Eight species of Gram-negative rods were evaluated against 15 antibiotics. From the 6,331 AST results, overall EA and CA were 95.4% and 94.3%, respectively. Overall VME, ME, and mE rates were 0.5%, 0.9%, and 4.8%, respectively. The Accelerate Pheno system has the unique ability to identify and provide phenotypic MIC and categorical AST results in a few hours directly from positive blood culture bottles and support accurate antimicrobial adjustment.

Keywords: FISH; MIC; antimicrobial susceptibility testing; bacteremia; blood culture; candidemia; identification; morphokinetic cellular analysis; phenotypic; rapid.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Flowchart of sample disposition after reevaluation of data with the 2017 software update. Footnotes a to g in the flowchart include additional information about the categories. For footnote a, the 560 excluded samples include the following reasons for exclusion: deviation from the protocol (n = 216), experiments halted (n = 26), experiments never run (n = 15), bottle received >8 h after positive result (n = 31), Gram staining shows no organism (n = 24), isolate not received at the reference laboratory (n = 18), isolate received more than 4 days after medium preparation (n = 3), ID reference growth failure (n = 29), nonpure isolate (n = 169), ID reference purity plate failure (n = 6), invalid ID reference result (n = 1), and Accelerate Pheno system run state not “complete” (n = 22). For footnote b with monomicrobic, a single on-panel organism was reported. For footnote c with polymicrobic, this category includes polymicrobial samples where the Accelerate PhenoTest BC kit ID results exactly match the reference results. For footnote d with false-positive, the false-positive category includes monomicrobial or polymicrobial runs containing any false-positive result(s). For footnote e with indeterminate, all indeterminate samples had only indeterminate/negative results. For footnote f with unresolved for fresh samples, of the 48 fresh unresolved false-positive results, 43 showed genus-level agreement, while the remaining five were one S. aureus called CoNS, one S. aureus plus Pantoea species mix called Klebsiella spp., one Pseudomonas putida called Citrobacter spp., one Lactococcus raffinolactis called Streptococcus spp., and one Streptococcus dysgalactiae subsp. equisimilis called E. faecium by the Accelerate Pheno system. For footnote g with unresolved for seeded samples, of the 24 seeded samples containing unresolved false-positive results, 15 showed genus-level agreement, one sample gave two false-positive results, while the remaining nine were one Pantoea sample called Enterobacter spp., one C. koseri sample called Citrobacter spp. plus Proteus spp., two C. koseri samples called Citrobacter spp. plus Klebsiella spp., one C. freundii sample called Citrobacter spp. plus Enterobacter spp., one C. koseri sample called Citrobacter spp. plus E. faecium plus Klebsiella spp., one E. cloacae complex sample called Enterobacter spp. plus P. aeruginosa, one E. faecalis sample called E. faecalis plus E. faecium, and one Streptococcus pyogenes sample called Streptococcus spp. plus E. faecium by the Accelerate Pheno system.

Comment in

References

    1. Sutton JP, Friedman B. 2006. Trends in septicemia hospitalizations and readmissions in selected HCUP states, 2005 and 2010. Statistical Brief #161. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD. - PubMed
    1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9. - DOI - PubMed
    1. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA, Weissfeld AS, Weinstein MP, Liebow EB, Wolk DM. 2016. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103. doi: 10.1128/CMR.00053-14. - DOI - PMC - PubMed
    1. Retamar P, Portillo MM, Lopez-Prieto MD, Rodriguez-Lopez F, de Cueto M, Garcia MV, Gomez MJ, Del Arco A, Munoz A, Sanchez-Porto A, Torres-Tortosa M, Martin-Aspas A, Arroyo A, Garcia-Figueras C, Acosta F, Corzo JE, Leon-Ruiz L, Escobar-Lara T, Rodriguez-Bano J, SAEI/SAMPAC Bacteremia Group. 2012. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56:472–478. doi: 10.1128/AAC.00462-11. - DOI - PMC - PubMed
    1. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, et al. 2017. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486–552. doi: 10.1097/CCM.0000000000002255. - DOI - PubMed

Publication types

MeSH terms

Substances